Anandamide Shows Stronger Pain-Blocking Effects Than 2-AG on Migraine-Related Nerve Fibers in Mice

In mouse meningeal nerve preparations, anandamide (AEA) produced stronger and longer-lasting suppression of pain-related nerve firing than 2-AG, suggesting FAAH inhibitors may be a promising migraine target.

Krivoshein, Georgii et al.·The journal of headache and pain·2025·Preliminary EvidenceAnimal StudyAnimal Study
RTHC-06863Animal StudyPreliminary Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

AEA reduced meningeal nerve firing more profoundly and for longer than 2-AG. AEA briefly activated slow-firing fibers (1-2 Hz), then persistently suppressed fast-firing fibers (>10 Hz). Only AEA inhibited subsequent capsaicin-induced firing. Mouse meninges showed higher FAAH activity and lower endogenous AEA levels.

Key Numbers

AEA suppressed fibers firing >10 Hz; briefly activated fibers at 1-2 Hz; endogenous AEA levels lower than 2-AG; FAAH activity higher than MAGL in meninges.

How They Did This

Ex vivo electrophysiological recordings from C57BL/6J mouse hemiskull preparations. 10 uM AEA or 2-AG applied with 50 mM KCl stimulation. Clustering and spectral analysis. LC-MS/MS measured endogenous enzyme activity and endocannabinoid levels.

Why This Research Matters

This study provides mechanistic evidence that boosting AEA through FAAH inhibition could reduce migraine-related nerve activation, offering a specific target rather than broad cannabinoid receptor activation.

The Bigger Picture

This study narrows the endocannabinoid focus to AEA and FAAH specifically for migraine, suggesting peripheral FAAH inhibition as a strategy that could avoid central side effects.

What This Study Doesn't Tell Us

Ex vivo mouse preparation. Single concentrations tested. Results may not translate to human meningeal physiology. Does not test FAAH inhibitors directly.

Questions This Raises

  • ?Would FAAH inhibitors reduce migraine frequency in clinical trials?
  • ?Do these AEA effects translate to human tissue?

Trust & Context

Key Stat:
AEA suppressed high-amplitude nerve fibers firing above 10 Hz
Evidence Grade:
Rigorous ex vivo methodology with multiple analytical approaches, but animal tissue study without in vivo validation.
Study Age:
2025 study presenting novel mechanistic data on endocannabinoids and meningeal pain signaling.
Original Title:
Differential inhibitory effects of endocannabinoids on neuronal firing of mouse meningeal afferents.
Published In:
The journal of headache and pain, 26(1), 112 (2025)
Database ID:
RTHC-06863

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Could endocannabinoids treat migraines?

This mouse study suggests boosting anandamide through FAAH inhibition could reduce migraine-related nerve firing. Clinical testing is still needed.

What is the difference between AEA and 2-AG?

Both are endocannabinoids, but AEA had stronger, longer-lasting effects on suppressing meningeal pain nerve firing in this study.

Read More on RethinkTHC

Cite This Study

RTHC-06863·https://rethinkthc.com/research/RTHC-06863

APA

Krivoshein, Georgii; Della Pietra, Adriana; Savinainen, Juha; van den Maagdenberg, Arn M J M; Giniatullin, Rashid. (2025). Differential inhibitory effects of endocannabinoids on neuronal firing of mouse meningeal afferents.. The journal of headache and pain, 26(1), 112. https://doi.org/10.1186/s10194-025-02041-z

MLA

Krivoshein, Georgii, et al. "Differential inhibitory effects of endocannabinoids on neuronal firing of mouse meningeal afferents.." The journal of headache and pain, 2025. https://doi.org/10.1186/s10194-025-02041-z

RethinkTHC

RethinkTHC Research Database. "Differential inhibitory effects of endocannabinoids on neuro..." RTHC-06863. Retrieved from https://rethinkthc.com/research/krivoshein-2025-differential-inhibitory-effects-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.